Market Overview:
The global cell-free protein synthesis market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for recombinant proteins and rising investments by pharmaceutical companies in cell-free protein synthesis technology. The global cell-free protein synthesis market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into E.
Product Definition:
Cell-free protein synthesis is the process of synthesizing proteins outside of cells. The importance of cell-free protein synthesis is that it allows for the production of large quantities of proteins, which can be used in research or therapeutic applications.
E.Coli Cell-Free Protein Synthesis:
The E. coli cell-free protein synthesis is a process in which the E. coli bacteria carry out the conversion of amino acids to proteins without involving any living cells, hence it is also known as extracellular protein synthesis (XPS). The process has several advantages such as it's cost-effective and offers high yields of functional proteins with minimal contamination from other cellular products; thus, making it an attractive option for large-scale production.
Rabbit Reticulocytes Cell-Free Protein Synthesis:
Rabbit reticulocytes cell-free protein synthesis is a process where the protein is synthesized in the absence of animal cells. In this process, amino acids are assembled according to rules that were discovered by Richard M. Schneider and Robert H. Grussner in 1970s.
Application Insights:
The academic and research institutes segment held the largest market share in terms of revenue in 2017. This is attributed to the rising number of R&D activities pertaining to bio-production of medicines and biopharmaceuticals. The pharmaceutical companies segment is anticipated to witness lucrative growth over the forecast period owing to increasing R&D expenditure on cell-free protein synthesis.
Cell-free protein synthesis has various applications such as production of proteins for use in vaccines, diagnosis, therapeutics, food & agriculture, cosmetics & personal care products among others. In addition, it finds application as a tool for structural biology studies and rational drug design which can be performed by chemically synthesizing large quantities of target proteins or related molecules with high accuracy using chemical methods followed by biological validation using living cells/tissue culture systems or animal models (mammalian).
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of companies involved in R&D activities and high adoption rate for advanced technologies across this region. Moreover, increasing focus on drug discovery by major pharmaceutical companies is expected to boost regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as growing economy, rising disposable income levels, and expanding healthcare infrastructure coupled with government initiatives pertaining towards cell-free protein technology development for disease diagnosis & vaccine production. In addition, increasing investments by various organizations are also contributing towards regional growth (e.g., The Japan Agency For Medical Research And Development).
Growth Factors:
- Increasing demand for cell-free protein synthesis products owing to their benefits over traditional methods of protein synthesis.
- Growing research and development activities in the field of cell-free protein synthesis, which is expected to result in the introduction of new and innovative products in the market.
- Rising investments by key players for expanding their production capacities to cater to the increasing demand from end users.
- Proliferation of contract research organizations (CROs) that are offering cell-free protein synthesis services, thereby aiding in the growth of this market segment.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell-free Protein Synthesis Market Research Report
By Type
E.Coli Cell-Free Protein Synthesis, Rabbit Reticulocytes Cell-Free Protein Synthesis, Wheat Germ Cell-Free Protein Synthesis, Insect Cells Cell-Free Protein Synthesis, Mammalian Cell-Free Protein Synthesis, Others, Cell-free Protein Synthesi
By Application
Pharmaceutical Companies, Academic/Research Institutes, Others
By Companies
Arbor Biosciences, Merck, Eurogentec, Fraunhofer IZI-BB, Promega, Amgen, Cell-free Protein Synthesi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Cell-free Protein Synthesis Market Report Segments:
The global Cell-free Protein Synthesis market is segmented on the basis of:
Types
E.Coli Cell-Free Protein Synthesis, Rabbit Reticulocytes Cell-Free Protein Synthesis, Wheat Germ Cell-Free Protein Synthesis, Insect Cells Cell-Free Protein Synthesis, Mammalian Cell-Free Protein Synthesis, Others, Cell-free Protein Synthesi
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Academic/Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Arbor Biosciences
- Merck
- Eurogentec
- Fraunhofer IZI-BB
- Promega
- Amgen
- Cell-free Protein Synthesi
Highlights of The Cell-free Protein Synthesis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- E.Coli Cell-Free Protein Synthesis
- Rabbit Reticulocytes Cell-Free Protein Synthesis
- Wheat Germ Cell-Free Protein Synthesis
- Insect Cells Cell-Free Protein Synthesis
- Mammalian Cell-Free Protein Synthesis
- Others
- Cell-free Protein Synthesi
- By Application:
- Pharmaceutical Companies
- Academic/Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell-free Protein Synthesis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell-free protein synthesis is the process of creating proteins without using cells. This can be done by using enzymes to create peptides or amino acids, or by chemically synthesizing the proteins.
Some of the key players operating in the cell-free protein synthesis market are Arbor Biosciences, Merck, Eurogentec, Fraunhofer IZI-BB, Promega, Amgen, Cell-free Protein Synthesi.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cell-free Protein Synthesis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cell-free Protein Synthesis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cell-free Protein Synthesis Market - Supply Chain
4.5. Global Cell-free Protein Synthesis Market Forecast
4.5.1. Cell-free Protein Synthesis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cell-free Protein Synthesis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cell-free Protein Synthesis Market Absolute $ Opportunity
5. Global Cell-free Protein Synthesis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cell-free Protein Synthesis Market Size and Volume Forecast by Type
5.3.1. E.Coli Cell-Free Protein Synthesis
5.3.2. Rabbit Reticulocytes Cell-Free Protein Synthesis
5.3.3. Wheat Germ Cell-Free Protein Synthesis
5.3.4. Insect Cells Cell-Free Protein Synthesis
5.3.5. Mammalian Cell-Free Protein Synthesis
5.3.6. Others
5.3.7. Cell-free Protein Synthesi
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cell-free Protein Synthesis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cell-free Protein Synthesis Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical Companies
6.3.2. Academic/Research Institutes
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cell-free Protein Synthesis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cell-free Protein Synthesis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cell-free Protein Synthesis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cell-free Protein Synthesis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cell-free Protein Synthesis Demand Share Forecast, 2019-2026
9. North America Cell-free Protein Synthesis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cell-free Protein Synthesis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cell-free Protein Synthesis Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical Companies
9.4.2. Academic/Research Institutes
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cell-free Protein Synthesis Market Size and Volume Forecast by Type
9.7.1. E.Coli Cell-Free Protein Synthesis
9.7.2. Rabbit Reticulocytes Cell-Free Protein Synthesis
9.7.3. Wheat Germ Cell-Free Protein Synthesis
9.7.4. Insect Cells Cell-Free Protein Synthesis
9.7.5. Mammalian Cell-Free Protein Synthesis
9.7.6. Others
9.7.7. Cell-free Protein Synthesi
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cell-free Protein Synthesis Demand Share Forecast, 2019-2026
10. Latin America Cell-free Protein Synthesis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cell-free Protein Synthesis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cell-free Protein Synthesis Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical Companies
10.4.2. Academic/Research Institutes
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cell-free Protein Synthesis Market Size and Volume Forecast by Type
10.7.1. E.Coli Cell-Free Protein Synthesis
10.7.2. Rabbit Reticulocytes Cell-Free Protein Synthesis
10.7.3. Wheat Germ Cell-Free Protein Synthesis
10.7.4. Insect Cells Cell-Free Protein Synthesis
10.7.5. Mammalian Cell-Free Protein Synthesis
10.7.6. Others
10.7.7. Cell-free Protein Synthesi
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cell-free Protein Synthesis Demand Share Forecast, 2019-2026
11. Europe Cell-free Protein Synthesis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cell-free Protein Synthesis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cell-free Protein Synthesis Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical Companies
11.4.2. Academic/Research Institutes
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cell-free Protein Synthesis Market Size and Volume Forecast by Type
11.7.1. E.Coli Cell-Free Protein Synthesis
11.7.2. Rabbit ReticulocytesCell-Free Protein Synthesis
11.7.3. Wheat Germ Cell-Free Protein Synthesis
11.7.4. Insect Cells Cell-Free Protein Synthesis
11.7.5. Mammalian Cell-Free Protein Synthesis
11.7.6. Others
11.7.7. Cell-free Protein Synthesi
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cell-free Protein Synthesis Demand Share, 2019-2026
12. Asia Pacific Cell-free Protein Synthesis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cell-free Protein Synthesis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cell-free Protein Synthesis Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical Companies
12.4.2. Academic/Research Institutes
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cell-free Protein Synthesis Market Size and Volume Forecast by Type
12.7.1. E.Coli Cell-Free Protein Synthesis
12.7.2. Rabbit Reticulocytes Cell-Free Protein Synthesis
12.7.3. Wheat Germ Cell-Free Protein Synthesis
12.7.4. Insect Cells Cell-Free Protein Synthesis
12.7.5. Mammalian Cell-Free Protein Synthesis
12.7.6. Others
12.7.7. Cell-free Protein Synthesi
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cell-free Protein Synthesis Demand Share, 2019-2026
13. Middle East & Africa Cell-free Protein Synthesis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cell-free Protein Synthesis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cell-free Protein Synthesis Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical Companies
13.4.2. Academic/Research Institutes
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cell-free Protein Synthesis Market Size and Volume Forecast by Type
13.7.1. E.Coli Cell-Free Protein Synthesis
13.7.2. Rabbit Reticulocytes Cell-Free Protein Synthesis
13.7.3. Wheat Germ Cell-Free Protein Synthesis
13.7.4. Insect Cells Cell-Free Protein Synthesis
13.7.5. Mammalian Cell-Free Protein Synthesis
13.7.6. Others
13.7.7. Cell-free Protein Synthesi
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cell-free Protein Synthesis Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Cell-free Protein Synthesis Market: Market Share Analysis
14.2. Cell-free Protein Synthesis Distributors and Customers
14.3. Cell-free Protein Synthesis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Arbor Biosciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eurogentec
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fraunhofer IZI-BB
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Promega
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Amgen
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cell-free Protein Synthesi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Over
